FDA study looks at pertussis vaccines and rising rates of whooping cough
A new study is helping to provide a better understanding of vaccines for whooping cough, the common name for the disease pertussis. Based on an animal model, the study conducted by the U.S. Food and Drug Administration More...
Princeton announces dates for receiving meningitis B vaccine
The New Jersey university, which has experienced eight cases of serogroup B meningococcal disease since March, has announced the dates they will be administering the vaccine that helps protect against meningococcal More...
Inovio’s MERS vaccine, SynCon DNA vaccine, induces ‘robust and durable immune responses’ in pre-clinical testing
Inovio Pharmaceuticals, Inc. announced recently that preclinical testing of a DNA synthetic vaccine for the virulent Middle East Respiratory Syndrome coronavirus (MERS) induced robust and durable immune responses, More...
What is Bexsero? How common is meningococcal disease serogroup B?
With the eighth case of meningococcal meningitis confirmed at Princeton University yesterday, and at least seven confirmed as Neisseria meningitis serotype B (MenB) with the most recent still pending, health officials More...
FDA approves H5N1 avian influenza vaccine for National Stockpile
The U.S. Food and Drug Administration today approved the first adjuvanted vaccine for the prevention of H5N1 influenza, commonly known as avian or bird flu. The vaccine, Influenza A (H5N1) Virus Monovalent Vaccine, More...
Princeton considers the use of Bexsero meningitis vaccine to curb spread of meningitis B
Following the seventh confirmed case of Neisseria meningitis B infection at Princeton University since March, the school is considering the use of a European Union/Australia -approved vaccine that will protect against More...
Themis Bioscience Chikungunya vaccine in clinical trials
Viennese biotech company Themis Bioscience announced the start of a phase I clinical study on its Chikungunya fever vaccine. The vaccine candidate, which is based on a standard anti-measles vaccine, will be evaluated More...
Herpes simplex vaccine candidate clinical trial launched
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced the launch of phase 1 clinical trials into an investigational genital herpes vaccine, More...
Japanese encephalitis vaccine from China gets WHO stamp of approval
A Japanese encephalitis (JE) vaccine manufactured in China has be prequalified by the World Health Organization (WHO) becoming the first Chinese-produced vaccine to receive this status. Ochlerotatus japonicusImage/CDC The More...
Investigational Norovirus vaccine reduces symptoms by more than 50 percent
An investigational vaccine appears generally well tolerated and effective against the most common strain of norovirus, reducing the main symptoms of the gastrointestinal (GI) infection, vomiting and/or diarrhea, More...
Advanced BioScience Laboratories chosen to help develop Shigella vaccine candidate
Advanced BioScience Laboratories, Inc. (ABL), a biomedical contract research and manufacturing organization to the biotechnology and pharmaceutical industries, announced earlier this week that it has been selected More...
WHO advises on H7N9 strain for vaccine development
The World Health Organization (WHO) has recommended a specific strain of avian influenza A(H7N9) to be used in the development of a H7N9 vaccine for pandemic purposes, according to a statement Thursday. This negatively-stained More...
H7N9 avian influenza vaccine candidate in clinical trials: NIH
Researchers at nine sites nationwide have begun testing in humans an investigational H7N9 avian influenza vaccine, according to a National Institutes of Health (NIH) news release today. This diagram depicts the More...
MenAfriVac meningitis vaccine an incredible success in Chad
A new meningitis vaccine, MenAfriVac or PsA-TT, has proved to be a raging success in after a mass vaccination campaign in the African country of Chad, according to new research published in The Lancet. MenAfriVac, a More...
PaxVax Initiates Phase 3 Clinical Trial Challenge Studies for Single-Dose Oral Cholera Vaccine
PRESS RELEASE Menlo Park, Calif., – September 6, 2013 – PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, today announced that it More...
Imaxio’s IMX313 pro-immunogenic technology used in tuberculosis vaccine human clinical trial
Imaxio, a biopharmaceutical company specializing in vaccines and genomics, announces today that IMX313, its proprietary pro-immunogenic technology, has been administered for the first time in humans in a tuberculosis More...
FDA approves FluLaval Quadrivalent influenza vaccine for persons three years and older
Pharmaceutical, biologics and vaccine company, GlaxoSmithKline (GSK), announced Friday that the Food and Drug Administration (FDA) has approved FluLaval Quadrivalent influenza vaccine for the active immunization More...
CVS/pharmacy survey shows that six out of 10 people consider getting the flu shot a ‘social responsibility’
A new survey from CVS/pharmacy released today found that less than half of those surveyed (46%) were more likely to get a flu shot this year following last season’s late flu outbreak. But many more – 59% More...
FDA approves Menveo quadrivalent meningococcal vaccine in children starting as early as two months
The Food and Drug Administration (FDA) approved the expanded age range for Menveo quadrivalent meningococcal vaccine for infants and toddlers from 2 months of age, according to a FDA approval letter. Neisseria More...
CDC gives update on HPV vaccination: ‘We’re dropping the ball’
During a Centers for Disease Control and Prevention (CDC) telebriefing today, health leaders gave an update on vaccination rates against human papillomavirus (HPV) and vaccine safety. CDC Director Thomas Frieden CDC More...